The drugmaker at the center of America’s opioid crisis is halting one of the practices that helped cause an epidemic of addiction and death.
Purdue Pharma, the manufacturer of the powerful opioid painkiller OxyContin, announced that it would no longer promote opioid drugs to physicians and has laid off more than 50 percent of its sales force.
“We have restructured and significantly reduced our commercial operation and will no longer be promoting our opioids to prescribers,” Purdue said in a statement. Only 200 sales representatives remain in the U.S., and they will no longer visit doctors’ offices to discuss their opioid medications.
This is a step in the right direction, but unfortunately, it comes too late for the communities devastated by the opioid crisis. The decision also comes at a convenient time for Purdue Pharmaceuticals.
Purdue, along with other opioid companies, is facing an increasing number of lawsuits from cities, counties and states accusing drug manufacturers of accelerating the opioid crisis, netting the company billions of dollars while sticking the states with the cost of rampant addiction.
Cory Watson Attorneys is taking a leadership role in this historic opioid litigation, representing county and city governments to help recover the staggering cost of this epidemic.
“The opioid crisis is fueled by pharmaceutical manufacturer Purdue, which has deceptively and illegally marketed opioids in order to significantly increase revenue and generate billions of dollars in sales,” said Cory Watson opioid attorney Jerome Tapley. “Purdue is misrepresenting the risks of these highly addictive painkillers, putting profits over people.”
The rampant use and abuse of opioids is devastating, resulting in unnecessary deaths as well as economic damages. Although these prescription drugs are highly addictive, they have been increasingly prescribed over the past two decades in the United States and have now reached epidemic levels.
“We are proud to fight the prescription drug epidemic, help restore our hurting communities, and hold drug manufacturers accountable for the role they have played in accelerating the opioid epidemic,” said Tapley.